期刊
DIABETES RESEARCH AND CLINICAL PRACTICE
卷 91, 期 2, 页码 159-163出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.diabres.2010.11.016
关键词
Chemerin; Renal function; Type 2 diabetes; Diabetic rephropathy; Creatinine clearance
Aim: Chemerin, a new adipocytokine, has been suggested to be linked to obesity-induced insulin resistance and type 2 diabetes. The association of plasma chemerin levels with diabetic nephropathy, however, is unknown. Therefore, this study aims to determine whether plasma chemerin levels are associated with renal function in type 2 diabetic patients. Methods: A total of 116 type 2 diabetic patients and 38 healthy subjects were enrolled in this study. Serum levels of chemerin were measured by enzyme-linked immunosorbent assay. Results: Serum chemerin was significantly elevated in type 2 diabetic patients with macro-albuminuria compared with control subjects and diabetic patients with normoalbuminuria and microalbuminuria. No differences were found in the level of serum chemerin between diabetic patients with normoalbuminuria and microalbuminuria and control subjects. Serum chemerin was positively correlated with age, body mass index (BMI), systolic blood pressure (SBP), C-reactive protein (CRP), blood urea nitrogen (BUN), serum creatinine and serum triglycerides, and negatively correlated with creatinine clearance Stepwise regression analysis showed that creatinine clearance and serum creatinine remained significantly associated with serum chemerin. Conclusion: Serum chemerin levels are strongly associated with renal function in diabetic patients. (C) 2010 Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据